Is Harmony Biosciences Holdings, Inc. (HRMY) a Buy, Sell, or Hold?
NASDAQ : HRMY
Harmony Biosciences Holdings, Inc.
$35.32 USD
-$0.48 (-1.34%)
- Volume
- 585.34K
- Average Volume
- 828.77K
- Market Capitalization
- $2.04B
- P/E Ratio
- 14.02
- Dividend Yield
- 0.00%
- Price Target
- $46.00
- Year High
- $40.87
- Year Low
- $25.52
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.58
Company Overview
NASDAQ
Jeffrey Dayno
Biotechnology
Healthcare
HRMY
293
US
USD
Liquidity Metrics
0.23
3.58
3.56
2.71
0.00
Sales & Valuation
$868.45M
2.27
2.24
5.98
5.91
Profitability
$2.71
$158.69M
16.20%
21.97%
17.19%
11.45%
P/E Metrics
14.02
-2.35
-2.35
Analyst Price Target & Rating
$46.00
$50.00
$36.00
4/5
13 Analysts
-23.22%
Financial Health Scores
5.38
5/9
$561.48M
$1.27B
$361.48M
$208M
Key Metrics (TTM)
$1.66B
1.85
7.12
3.58
17.19%
12.50%
7.13%
16.72%
$29.87
4 days
Company Executives
| Name | Title |
|---|---|
| Tricia Glover | Chief Compliance Officer |
| Brennan Doyle | Vice President & Head of Investor Relations |
| Jeffrey Dayno | President, Chief Executive Officer & Director |
| Christian Ulrich | Executive VP, General Counsel & Corporate Secretary |
| Glenn Reicin | Chief Financial Officer |
| Jeffrey S. Aronin | Founder & Non-Executive Chairman |
| Peter Anastasiou | Chief Operating Officer |
| Kumar Budur | Executive Vice President and Chief Medical & Scientific Officer |
| Adam Zaeske | Executive Vice President & Chief Commercial Officer |
| Andrew Serafin | Executive Vice President & Chief Strategy Officer |
Poll Results
No votes yet today — be the first to share your view!
About Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical firm dedicated to developing and marketing therapies for individuals in the United States who suffer from rare neurological conditions. Their flagship product, WAKIX, is a prescription medication designed to treat excessive daytime sleepiness in adult patients diagnosed with narcolepsy. The company, which was founded in 2017, was formerly known as Harmony Biosciences II, Inc. before adopting its current name in February 2020. Harmony Biosciences Holdings, Inc. operates out of Plymouth Meeting, Pennsylvania. ...
Harmony Biosciences (HRMY) Soars 10.0%: Is Further Upside Left in the Stock?
2026-07-22 09:01:12
Harmony Biosciences (HRMY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Harmony Biosciences To Report Second Quarter 2026 Financial Results On August 4, 2026
2026-07-21 08:05:00
PLYMOUTH MEETING, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will report second quarter 2026 financial results on Tuesday, August 4, 2026, before the open of the U.S. financial markets. Harmony will host a conference call and webcast on August 4, 2026, at 8:30 a.m. ET to discuss the results.
HRMY Posts Preliminary Q2 Revenues, Announces CFO Transition
2026-07-17 15:26:08
Harmony Biosciences posts preliminary Q2 2026 Wakix revenues of about $261M, up 30% year over year, while reaffirming full-year guidance despite a CFO transition.
2026-07-16 08:30:00
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced preliminary, unaudited second quarter 2026 net product revenue for WAKIX® (pitolisant) of approximately $261 million, representing a new quarterly revenue record for the Company and growth of 30% year over year and 21% growth for Q2 over Q1. These results underscore continued strong demand for WAKIX, disciplined commercial execution across the franchise and sustained momentum through the fi.
2026-07-15 10:55:15
The mean of analysts' price targets for Harmony Biosciences (HRMY) points to a 27.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
HRMY vs. AMGN: Which Stock Is the Better Value Option?
2026-07-14 12:40:26
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Harmony Biosciences Holdings, Inc. (HRMY) and Amgen (AMGN). But which of these two companies is the best option for those looking for undervalued stocks?
5 Low Price-to-Book Value Stocks to Buy in July for Solid Returns
2026-07-14 11:31:06
Five low price-to-book stocks pass our value screens with low P/B, P/S and PEG metrics, highlighting their earnings growth potential.
Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?
2026-07-14 10:40:22
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Frequently Asked Questions
-
What is the current Harmony Biosciences Holdings, Inc. (HRMY) stock price?
-
Harmony Biosciences Holdings, Inc.(NASDAQ:HRMY) stock price is $35.32 in the last trading session. During the trading session, HRMY stock reached the peak price of $40.87 while $25.52 was the lowest point it dropped to. The percentage change in HRMY stock occurred in the recent session was --1.34% while the dollar amount for the price change in HRMY stock was -$0.48.
-
HRMY's industry and sector of operation?
-
The NASDAQ listed HRMY is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of HRMY?
-
Tricia Glover | Chief Compliance Officer
Brennan Doyle | Vice President & Head of Investor Relations
Jeffrey Dayno | President, Chief Executive Officer & Director
Christian Ulrich | Executive VP, General Counsel & Corporate Secretary
Glenn Reicin | Chief Financial Officer -
How many employees does HRMY have?
-
Number of HRMY employees currently stands at 293. HRMY operates from 630 West Germantown Pike, Plymouth Meeting, PA 19462, US.
-
Link for HRMY official website?
-
Official Website of HRMY is: https://www.harmonybiosciences.com
-
How do I contact HRMY?
-
HRMY could be contacted at phone #484 539 9800 and can also be accessed through its website. HRMY operates from 630 West Germantown Pike, Plymouth Meeting, PA 19462, US.
-
How many shares of HRMY are traded daily?
-
The average number of HRMY shares traded daily for last 3 months was 828.77K.
-
What is the market cap of HRMY currently?
-
The market value of HRMY currently stands at $2.04B with its latest stock price at $35.32